von Willebrand Disease Clinical Presentation
- Author: Eleanor S Pollak, MD; Chief Editor: Emmanuel C Besa, MD more...
History and Physical Examination
History
The most common symptoms of von Willebrand disease (vWD) include nosebleeds and hematomas. Prolonged bleeding from trivial wounds, oral cavity bleeding, and excessive menstrual bleeding are common. Gastrointestinal bleeding rarely occurs. Other symptoms include the following[4, 5] :
- Easy bruising - Common but nonspecific
- Prolonged bleeding - After minor trauma to skin or mucous membranes
- Severe hemorrhage - After major surgery; less common
- Delayed bleeding - May occur up to several weeks after surgery
- Heavy bleeding - Common after tooth extraction or other oral surgery, such as tonsillectomy and adenoidectomy
- Menorrhagia - Common presenting complaint in women
- Exacerbation of bleeding symptoms - After ingestion of aspirin
- Amelioration of bleeding symptoms - With use of oral contraceptives
Physical examination
Physical examination findings are usually normal. However, patients may show physical sequelae, such as bleeding or bruises.
Udvardy ML, Szekeres-Csiki K, Hársfalvi J. Novel evaluation method for densitometric curves of von Willebrand factor multimers and a new parameter (M(MW)) to describe the degree of multimersation. Thromb Haemost. Aug 2009;102(2):412-7. [Medline].
Sutherland MS, Cumming AM, Bowman M, et al. A novel deletion mutation is recurrent in von Willebrand disease types 1 and 3. Blood. Jul 30 2009;114(5):1091-8. [Medline].
Byams VR, Kouides PA, Kulkarni R, et al. Surveillance of female patients with inherited bleeding disorders in United States Haemophilia Treatment Centres. Haemophilia. Jul 2011;17 Suppl 1:6-13. [Medline].
Nichols WL, Hultin MB, James AH, et al, and the NHLBI von Willebrand Disease Expert Panel. The Diagnosis, Evaluation, and Management of von Willebrand Disease. Bethesda, Md: National Heart, Lung, and Blood Institute. NIH publication no. 08-5832. December 2007;Accessed September 30, 2008. Available at http://www.nhlbi.nih.gov/guidelines/vwd/index.htm.
Rodeghiero F, Castaman G, Tosetto A. How I treat von Willebrand disease. Blood. Aug 6 2009;114(6):1158-65. [Medline]. [Full Text].
Franchini M, Targher G, Montagnana M, Lippi G. Antithrombotic prophylaxis in patients with von Willebrand disease undergoing major surgery: when is it necessary?. J Thromb Thrombolysis. Aug 2009;28(2):215-9. [Medline].
Di Paola J, Lethagen S, Gill J, et al. Presurgical pharmacokinetic analysis of a von Willebrand factor/factor VIII (VWF/FVIII) concentrate in patients with von Willebrand's disease (VWD) has limited value in dosing for surgery. Haemophilia. Sep 2011;17(5):752-8. [Medline].

